Skip to content

Indoor Air and Children Health Study

Cardiopulmonary Health Effects of Indoor Air Purification and Different Indoor Environmental Factors Among School Children in Beijing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03319056
Enrollment
48
Registered
2017-10-24
Start date
2017-12-11
Completion date
2018-04-01
Last updated
2019-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Disease

Brief summary

The objective of this study is to investigate the cardiopulmonary health effects of indoor air purification and different indoor environmental factors among school students in Beijing.

Detailed description

This randomized, double-blind crossover study was conducted to explore the cardiopulmonary effects of ionization air purification among 48 children in Beijing. Real or sham purification was performed in classrooms for 5 weekdays in a random order with a 2-month wash-out period. During the study periods, different indoor environmental factors were monitored including size-fractionated particulate matter (PM), black carbon (BC), ozone, carbon dioxide (CO2), negative air ions (NAI), noise, temperature and relative humidity, which were controlled as confounders in the analysis of the effects of indoor air purification. In addition, we analyzed the cardiopulmonary effects of those environmental factors on the children.

Interventions

active- or sham-mode air purifier used in 6 classrooms in a school with a crossover design

Sponsors

Peking University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
10 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* living in Beijing for more than two consecutive years; * living in school dormitories from Monday to Friday.

Exclusion criteria

* suffering any health condition; * having asthma or thoracic surgery history.

Design outcomes

Primary

MeasureTime frameDescription
Levels of lung function indicators10 weekdays for intervention (active or sham) and 2 wash-out monthsLung function test was conducted including forced expiratory volume in one second (FEV1) and peak expiratory flow (PEF).

Secondary

MeasureTime frameDescription
Changes in autonomic cardiac function10 weekdays for intervention (active or sham) and 2 wash-out monthsAmbulatory electrocardiogram (ECG) was monitored including heart rate (HR) and heart rate variability (HRV).
Level of respiratory inflammation10 weekdays for intervention (active or sham) and 2 wash-out monthsFractional exhaled nitric oxide (FeNO) test was conducted.
Changes in ST-segment elevation10 weekdays for intervention (active or sham) and 2 wash-out monthsAmbulatory electrocardiogram (ECG) was monitored.
Levels of oxidative stress in Exhaled Breath Condensate (EBC)10 weekdays for intervention (active or sham) and 2 wash-out monthsEBC was collected using a designated device for oxidative stress analysis.
Levels of urinary metabolomics10 weekdays for intervention (active or sham) and 2 wash-out monthsUrine samples were collected for metabolomics analysis.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026